isospaglumic acid has been researched along with Cognitive Dysfunction in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alt, J; Barker, PB; Brandt, J; Calabresi, PA; Crainiceau, CM; Grishkan, I; Kaplin, AI; Pletnikov, MV; Pomper, MG; Rahn, KA; Rais, R; Rojas, C; Slusher, BS; Stathis, M; Watkins, CC | 1 |
1 other study(ies) available for isospaglumic acid and Cognitive Dysfunction
Article | Year |
---|---|
Inhibition of glutamate carboxypeptidase II (GCPII) activity as a treatment for cognitive impairment in multiple sclerosis.
Topics: Adult; Analysis of Variance; Animals; Cognitive Dysfunction; Dipeptides; Encephalomyelitis, Autoimmune, Experimental; Female; Flow Cytometry; Glutamate Carboxypeptidase II; Hippocampus; Humans; Magnetic Resonance Spectroscopy; Male; Mass Spectrometry; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Neuropsychological Tests; Organophosphorus Compounds | 2012 |